Small Diameter Vascular Graft Produced by a Hybrid Method
US-2015359619-A1 · Dec 17, 2015 · US
US2017232145A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017232145-A1 |
| Application number | US-201715583432-A |
| Country | US |
| Kind code | A1 |
| Filing date | May 1, 2017 |
| Priority date | Sep 4, 2012 |
| Publication date | Aug 17, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides natural multi-composite bone implants such as bone-connective tissue-bone and osteochondral implants for the replacement and/or repair of, for example and in particular a damaged or defective bone-meniscus-bone joint or a bone-patella tendon-bone joint or osteochondral lesions, methods of preparing the composites and uses thereof. The invention also provides natural or native composite bone-connective tissue-bone and osteochondral matrices or scaffolds that are substantially decellularised for subsequent transplantation/implantation.
Opening claim text (preview).
1 .- 31 . (canceled) 32 . A method of preparing a decellularised multi-composite donor bone tissue matrix for subsequent implantation into a host comprising the steps of: (i) freezing and thawing the composite tissue matrix; (ii) subjecting bone blocks to a fluid jet; (iii) ultrasonicating the composite tissue matrix (iv) in the instance of the multi-composite tissue matrix comprises a bone-connective tissue-bone structure, teasing apart fascicles at an enthesis region; (v) incubating the composite tissue matrix in a hypotonic solution; (vi) incubating the composite tissue matrix in a hypotonic solution comprising an anionic detergent; (vii) subjecting the composite tissue matrix to hypotonic or isotonic washes; (viii) incubating the tissue in a solution comprising at least one nuclease enzyme; (ix) washing the composite tissue matrix; and (x) further washing of the composite tissue matrix. 33 . The method of claim 32 , wherein the temperature of the freezing steps is between −10 to −85° C. 34 . The method according to claim 32 , wherein the fluid of the fluid jet is pressurised water or phosphate buffered saline (PBS). 35 . The method according to claim 34 , wherein between 250-600 ml of fluid is used to water pile each bone block. 36 . The method according to claim 32 , wherein the ultrasonic energy is applied to a solution in which the multi-composite donor bone tissue matrix is immersed. 37 . The method according to claim 32 , wherein step (v) comprises firstly incubating the composite tissue matrix in a hypotonic solution under freeze/thaw conditions and subsequently a wash in hypotonic buffer under non freeze/thaw conditions. 38 . The method according to claim 32 , further including a storage step the step comprising storing the decellularised composite donor bone-connective tissue-bone tissue matrix at between − 10 to − 85° C. 39 . The method according to claim 32 , further including the step of incubating the composite tissue matrix with an oxidising agent prior to a final wash. 40 . A natural decellularised multi-composite bone transplant product produced by the method of claim 32 . 41 . A method of treatment of an individual requiring knee repair or replacement surgery comprising the steps of preparing a decellularised natural donor bone-medial meniscal-bone transplant product according to the method of claim 32 and replacing the defective or damaged knee joint with the decellularised natural bone-medial meniscus-bone transplant product. 42 . A method of treatment of an individual requiring patella tendon knee repair or replacement surgery comprising the steps of preparing a decellularised natural donor bone-patella tendon-bone transplant product according to the method of claim 32 and replacing the defective or damaged area with the decellularised natural bone-patella tendon-bone transplant product. 43 . A method of treatment of an individual requiring osteochondral repair or replacement surgery comprising the steps of preparing a decellularised natural donor osteochondral transplant product according to the method of claim 32 and replacing the defective or damaged area with the decellularised natural osteochondral transplant product.
subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment · CPC title
Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells · CPC title
Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking · CPC title
for reconstruction of bones; weight-bearing implants · CPC title
characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.